Please assess the completion status of the following clinical trial:

Trial Title: Vitamin D Supplementation in Polymorphic Light Eruption

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Confirmed diagnosis of PLE by typical patient history, typical histology of skin lesions and/or positive photo provocation results~Exclusion Criteria:~* Allergy or intolerance to Oleovit D3 or Coconut/palm kernel~* Presence or history of malignant skin tumors~* Dysplastic melanocytic nevus syndrome~* Photosensitive diseases such as porphyria, chronic actinic dermatitis, xeroderma pigmentosum, and basal cell nevus syndrome; autoimmune disorders such as lupus erythematosus or dermatomyositis~* Sarcoid~* Renal dysfunction~* Psychiatric disorder~* Pregnancy or breastfeeding~* Topical treatment with vitamin D derivates within 3 months~* Oral treatment with vitamin D within 6 months~* Antinuclear antibodies such as anti-ds-DNA or anti- Ro/La~* 25-hydroxy vitamin D serum levels \> 30ng/ml at screening visit~* Serum hypercalcemia \> 2,65 nmol/L~* Treatment with thiazides or glycosides~* Systemic treatment with steroids and/or other immunosuppressive drugs within 4 weeks~* UV exposure in test fields within 8 weeks before the start of the study~* General poor health status

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Vitamin D3 (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).